Jan David Lanzer

Jan David Lanzer

Auto-generated profile, based on publicly available information

Jan David Lanzer

Heidelberg University, Faculty of Medicine, and Heidelberg University Hospital, Institute for Computational Biomedicine, Heidelberg, Germany

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2021 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
RFRicardo O. Ramirez Flores
Ricardo O. Ramirez Flores
JLJan D. Lanzer
Jan D. Lanzer
CHChristian Holland
Christian Holland
FLFlorian Leuschner
Florian Leuschner
PMPatrick Most
Patrick Most
JSJulio Saez‐Rodriguez
Julio Saez‐Rodriguez
Background: Transcriptomic studies have contributed to fundamental knowledge of myocardial remodeling in human heart failure (HF). However, the key HF genes reported are often inconsistent between studies, and systematic efforts to integrate evidence from multiple patient cohorts are lacking. Here, we aimed to provide a framework for comprehensive comparison and analysis of publicly available data sets resulting in an unbiased consensus transcriptional signature of human end‐stage HF. Methods and Results: We curated and uniformly processed 16 public transcriptomic studies of left ventricular samples from 263 healthy and 653 failing human hearts. First, we evaluated the degree of consistency between studies by using linear classifiers and overrepresentation analysis. Then, we meta‐analyzed the deregulation of 14 041 genes to extract a consensus signature of HF. Finally, to functionally characterize this signature, we estimated the activities of 343 transcription factors, 14 signaling pathways, and 182 micro RNAs, as well as the enrichment of 5998 biological processes. Machine learning approaches revealed conserved disease patterns across all studies independent of technical differences. These consistent molecular changes were prioritized with a meta‐analysis, functionally characterized and validated on external data. We provide all results in a free public resource ( https://saezlab.shinyapps.io/reheat/ ) and exemplified usage by deciphering fetal gene reprogramming and tracing the potential myocardial origin of the plasma proteome markers in patients with HF. Conclusions: Even though technical and sampling variability confound the identification of differentially expressed genes in individual studies, we demonstrated that coordinated molecular responses during end‐stage HF are conserved. The presented resource is crucial to complement findings in independent studies and decipher fundamental changes in failing myocardium.

23 September 2024 in Basic Research in Cardiology
Verified
Journal Article
Open access
PDF file
JLJan D. Lanzer
Jan D. Lanzer
LWLaura M. Wienecke
Laura M. Wienecke
RFRicardo O. Ramirez Flores
Ricardo O. Ramirez Flores
MZMaura M. Zylla
Maura M. Zylla
CKCelina Kley
Celina Kley
FLFlorian Leuschner
Florian Leuschner
Inflammation, fibrosis and metabolic stress critically promote heart failure with preserved ejection fraction (HFpEF). Exposure to high-fat diet and nitric oxide synthase inhibitor N[w]-nitro-l-arginine methyl ester (L-NAME) recapitulate features of HFpEF in mice. To identify disease-specific traits during adverse remodeling, we profiled interstitial cells in early murine HFpEF using single-cell RNAseq (scRNAseq). Diastolic dysfunction and perivascular fibrosis were accompanied by an activation of cardiac fibroblast and macrophage subsets. Integration of fibroblasts from HFpEF with two murine models for heart failure with reduced ejection fraction (HFrEF) identified a catalog of conserved fibroblast phenotypes across mouse models. Moreover, HFpEF-specific characteristics included induced metabolic, hypoxic and inflammatory transcription factors and pathways, including enhanced expression of Angiopoietin-like 4 (Angptl4) next to basement membrane compounds, such as collagen IV (Col4a1). Fibroblast activation was further dissected into transcriptional and compositional shifts and thereby highly responsive cell states for each HF model were identified. In contrast to HFrEF, where myofibroblast and matrifibrocyte activation were crucial features, we found that these cell states played a subsidiary role in early HFpEF. These disease-specific fibroblast signatures were corroborated in human myocardial bulk transcriptomes. Furthermore, we identified a potential cross-talk between macrophages and fibroblasts via SPP1 and TNFɑ with estimated fibroblast target genes including Col4a1 and Angptl4. Treatment with recombinant ANGPTL4 ameliorated the murine HFpEF phenotype and diastolic dysfunction by reducing collagen IV deposition from fibroblasts in vivo and in vitro. In line, ANGPTL4, was elevated in plasma samples of HFpEF patients and particularly high levels associated with a preserved global-longitudinal strain. Taken together, our study provides a comprehensive characterization of molecular fibroblast activation patterns in murine HFpEF, as well as the identification of Angiopoietin-like 4 as central mechanistic regulator with protective effects.

12 August 2020 in Current Heart Failure Reports
Verified
Journal Article
Open access
PDF file
JLJan D. Lanzer
Jan D. Lanzer
FLFlorian Leuschner
Florian Leuschner
RKRafael Kramann
Rafael Kramann
RLRebecca T. Levinson
Rebecca T. Levinson
JSJulio Saez-Rodriguez
Julio Saez-Rodriguez
Purpose of Review: The goal of this review is to summarize the state of big data analyses in the study of heart failure (HF). We discuss the use of big data in the HF space, focusing on “omics” and clinical data. We address some limitations of this data, as well as their future potential.Recent Findings: Omics are providing insight into plasmal and myocardial molecular profiles in HF patients. The introduction of single cell and spatial technologies is a major advance that will reshape our understanding of cell heterogeneity and function as well as tissue architecture. Clinical data analysis focuses on HF phenotyping and prognostic modeling.Summary: Big data approaches are increasingly common in HF research. The use of methods designed for big data, such as machine learning, may help elucidate the biology underlying HF. However, important challenges remain in the translation of this knowledge into improvements in clinical care.

31 October 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
JLJan D. Lanzer
Jan D. Lanzer
RFRicardo O. Ramirez Flores
Ricardo O. Ramirez Flores
JBJosé Liñares Blanco
José Liñares Blanco
MSMarco Steier
Marco Steier
ARAshraf Rangrez
Ashraf Rangrez
JSJulio Saez-Rodriguez
Julio Saez-Rodriguez
Impaired cardiac function in heart failure (HF) involves tissue remodeling through multicellular coordination. Although individual bulk and single-nucleus transcriptomics studies have offered insights, they have not been integrated to study conserved tissue-wide responses, limiting understanding of multicellular processes in cardiac remodeling necessary for therapeutic translation. Here, we integrate 25 studies of bulk and single-nucleus transcriptomics, spanning 1524 individuals, to define consensus multicellular programs associated with HF. These programs reveal conserved fibrotic, inflammatory, metabolic, and hypertrophic processes, with fibroblast activity consistently predicting cardiomyocyte stress. Our integration revealed that multicellular programs in HF are largely independent of tissue composition, and that fibroblast activation reflects a broad phenotypic shift rather than solely the emergence of discrete subtypes. Projecting external datasets onto these programs showed that clinical recovery aligns with reversion of disease-associated programs. This integrative analysis across studies establishes a public reference for the exploration of multicellular coordination in HF.

24 July 2023 in BMC Medicine
Verified
Journal Article
Open access
PDF file
JLJan D. Lanzer
Jan D. Lanzer
AVAlberto Valdeolivas
Alberto Valdeolivas
MPMark Pepin
Mark Pepin
HHHauke Hund
Hauke Hund
JBJohannes Backs
Johannes Backs
RLRebecca T. Levinson
Rebecca T. Levinson
Background: Comorbidities are expected to impact the pathophysiology of heart failure (HF) with preserved ejection fraction (HFpEF). However, comorbidity profiles are usually reduced to a few comorbid disorders. Systems medicine approaches can model phenome-wide comorbidity profiles to improve our understanding of HFpEF and infer associated genetic profiles. Methods: We retrospectively explored 569 comorbidities in 29,047 HF patients, including 8062 HFpEF and 6585 HF with reduced ejection fraction (HFrEF) patients from a German university hospital. We assessed differences in comorbidity profiles between HF subtypes via multiple correspondence analysis. Then, we used machine learning classifiers to identify distinctive comorbidity profiles of HFpEF and HFrEF patients. Moreover, we built a comorbidity network (HFnet) to identify the main disease clusters that summarized the phenome-wide comorbidity. Lastly, we predicted novel gene candidates for HFpEF by linking the HFnet to a multilayer gene network, integrating multiple databases. To corroborate HFpEF candidate genes, we collected transcriptomic data in a murine HFpEF model. We compared predicted genes with the murine disease signature as well as with the literature. Results: We found a high degree of variance between the comorbidity profiles of HFpEF and HFrEF, while each was more similar to HFmrEF. The comorbidities present in HFpEF patients were more diverse than those in HFrEF and included neoplastic, osteologic and rheumatoid disorders. Disease communities in the HFnet captured important comorbidity concepts of HF patients which could be assigned to HF subtypes, age groups, and sex. Based on the HFpEF comorbidity profile, we predicted and recovered gene candidates, including genes involved in fibrosis (COL3A1, LOX, SMAD9, PTHL), hypertrophy (GATA5, MYH7), oxidative stress (NOS1, GSST1, XDH), and endoplasmic reticulum stress (ATF6). Finally, predicted genes were significantly overrepresented in the murine transcriptomic disease signature providing additional plausibility for their relevance. Conclusions: We applied systems medicine concepts to analyze comorbidity profiles in a HF patient cohort. We were able to identify disease clusters that helped to characterize HF patients. We derived a distinct comorbidity profile for HFpEF, which was leveraged to suggest novel candidate genes via network propagation. The identification of distinctive comorbidity profiles and candidate genes from routine clinical data provides insights that may be leveraged to improve diagnosis and identify treatment targets for HFpEF patients. Graphical

6 November 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
JLJan D. Lanzer
Jan D. Lanzer
RFRicardo O. Ramirez Flores
Ricardo O. Ramirez Flores
JLJose Liñares-Blanco
Jose Liñares-Blanco
JSJulio Saez-Rodriguez
Julio Saez-Rodriguez
Heart failure (HF) is characterized by severely reduced cardiac function and tissue remodeling, driven by complex multicellular regulatory processes. Extensive studies have generated molecular profiles at both bulk and single-cell levels; however, systematic integration that describes tissue-wide changes as a function of cell type coordination remains challenging. This disconnect hampers our understanding of the complex multicellular interactions driving heart failure, limiting our ability to translate molecular insights into actionable therapeutic strategies. Here, we integrated bulk and single-cell transcriptional profiles from cardiac tissues of HF and control patients across 25 studies, covering 1,524 individuals and seven cell-types, to delineate consensus multicellular transcriptional changes associated with cardiac remodeling. Our analyses revealed conserved cellular coordination events involving fibrotic, metabolic, inflammatory, and hypertrophic mechanisms, with fibroblasts playing a central role in predicting cardiomyocyte stress. Further analysis of fibroblast populations suggested that their activation in HF represents a broad phenotypic shift rather than solely accumulating distinct cell states. The integration of bulk and single-cell data within our data collection indicated that transcriptional responses to HF across cell types occur independently of tissue composition. Mapping independent data into our consensus programs demonstrated that recovery after left ventricular assist device implantation aligns with molecular recovery, highlighting the clinical relevance of the multicellular molecular state. Overall, our work synthesizes independent cardiac transcriptomics studies and makes the conserved HF associated insights available, establishing a reference for detailed exploration of HF-related multicellular molecular events. Graphical Abstract